Continuing Education Company 29th Annual Hypertension, Diabetes, & Dyslipidemia Conference 2025

Introduction

The Continuing Education Company 29th Annual Hypertension, Diabetes, & Dyslipidemia Conference 2025 is a comprehensive CME-focused educational program dedicated to evidence-based management of cardiometabolic disease and cardiovascular risk reduction. Hosted in Savannah from June 18–20, 2025, the conference brings together nationally recognized experts in hypertension, diabetes, lipidology, nephrology, preventive cardiology, and metabolic medicine to provide practical clinical updates for healthcare professionals managing chronic cardiometabolic conditions.

Organized by Continuing Education Company, the conference emphasizes modern treatment strategies, evolving clinical guidelines, and multidisciplinary approaches to improving outcomes in patients with hypertension, diabetes mellitus, dyslipidemia, obesity, and cardiovascular disease risk factors. Through focused lectures, evidence-based discussions, and clinically practical recommendations, the curriculum supports improved decision-making in both primary care and specialty practice.

The conference format combines CME-accredited educational sessions with flexible scheduling, allowing clinicians to engage in focused half-day learning while maintaining opportunities for networking, collaboration, and professional development.

Files Included

The Continuing Education Company 29th Annual Hypertension, Diabetes, & Dyslipidemia Conference 2025 educational package includes focused cardiometabolic medicine learning resources.

Included resources:

• 3 educational videos
• 19 downloadable PDFs
• Evidence-based hypertension management lectures
• Diabetes and metabolic disease updates
• Lipidology and cardiovascular prevention education
• Guideline-focused chronic disease management discussions
• Cardiometabolic risk reduction strategies

Additional highlights:

• Total size: 42 GB
• CME-accredited conference content
• Expert-led multidisciplinary faculty presentations
• Practical chronic disease management education

These resources support continuing medical education in hypertension, diabetes care, dyslipidemia management, lipidology, preventive cardiology, and cardiometabolic medicine.

Why This Course Is Important

Hypertension, diabetes, dyslipidemia, obesity, and chronic kidney disease remain among the most significant contributors to cardiovascular morbidity and mortality worldwide. Rapid advances in cardiometabolic therapeutics—including GLP-1 receptor agonists, SGLT2 inhibitors, novel lipid-lowering agents, and updated blood pressure management strategies—have transformed clinical practice and preventive cardiovascular care.

At the same time, clinicians must navigate increasingly complex guideline recommendations, multimorbidity management, cardiovascular risk stratification, and individualized treatment approaches for diverse patient populations including older adults, patients with renal disease, and those with resistant hypertension or severe dyslipidemia.

The Continuing Education Company 29th Annual Hypertension, Diabetes, & Dyslipidemia Conference 2025 addresses these challenges through focused expert-led education emphasizing practical clinical implementation, evidence-based treatment strategies, and long-term cardiometabolic risk reduction.

What Participants Will Learn

Participants completing this course will strengthen their expertise in cardiometabolic disease management, cardiovascular prevention, and evidence-based chronic disease treatment strategies.

Learning objectives include:

• Applying updated hypertension treatment guidelines
• Optimizing diabetes management and cardiometabolic risk reduction
• Improving dyslipidemia and lipid disorder treatment strategies
• Understanding controversies and evolving recommendations in chronic disease care
• Integrating evidence-based preventive cardiology approaches into practice
• Managing cardiovascular risk in patients with metabolic disease
• Applying individualized treatment approaches for high-risk patients
• Evaluating emerging therapies in obesity, diabetes, and lipidology
• Improving long-term outcomes through multidisciplinary care strategies
• Translating clinical trial evidence into practical patient management

The curriculum integrates preventive cardiology, hypertension management, diabetes medicine, lipidology, nephrology, and metabolic disease care into a clinically practical educational experience.

Full Course Topics & Lectures

Hypertension Management

Contemporary Hypertension Guidelines

Resistant Hypertension

Cardiovascular Risk Stratification

Blood Pressure Treatment Strategies

Hypertension and Kidney Disease

Diabetes & Metabolic Disease

Type 2 Diabetes Management

Cardiometabolic Risk Reduction

Obesity and Metabolic Syndrome

Advanced Diabetes Pharmacotherapy

Diabetes and Cardiovascular Disease

Dyslipidemia & Lipidology

Lipid Disorder Management

LDL-C, ApoB & Triglyceride Management

Preventive Lipidology

Familial and Complex Dyslipidemias

Cardiovascular Prevention Strategies

Cardiovascular Prevention

Preventive Cardiology Approaches

ASCVD Risk Reduction

Antiplatelet and Preventive Therapies

Lifestyle Modification and Risk Reduction

Multidisciplinary Cardiovascular Prevention

Kidney Disease & Cardiometabolic Health

CKD and Cardiovascular Disease

Diabetes and Kidney Protection

Renal Risk Reduction Strategies

Integrated Cardiometabolic Care

Obesity & Weight Management

Biology of Obesity

Weight Loss Pharmacotherapy

Obesity-Associated Cardiovascular Risk

Long-Term Metabolic Management

Emerging Therapies & Clinical Controversies

New Cardiometabolic Medications

Evolving Clinical Guidelines

Evidence-Based Therapeutic Updates

Controversies in Chronic Disease Management

Educational Experience & Learning Features

The Continuing Education Company 29th Annual Hypertension, Diabetes, & Dyslipidemia Conference 2025 combines expert-led cardiometabolic education with clinically practical disease management strategies.

Educational features include:

• Expert faculty lectures
• CME-accredited educational sessions
• Guideline-focused chronic disease reviews
• Practical hypertension management education
• Diabetes and obesity treatment updates
• Lipidology and preventive cardiology instruction
• Evidence-based therapeutic discussions
• Multidisciplinary cardiometabolic education
• Downloadable PDF learning materials
• Flexible conference learning format

The curriculum integrates hypertension, diabetes, lipidology, preventive cardiology, obesity medicine, and nephrology into a comprehensive chronic disease management educational platform.

Distinguished Faculty

The conference features nationally recognized experts in cardiometabolic medicine and cardiovascular prevention, including:

• Jan N. Basile
• Jennifer L. Cluett
• Marc-Andre Cornier
• W. Timothy Garvey
• Daniel W. Jones
• Seth Martin
• Katherine R. Tuttle
• James A. Underberg

Their expertise spans hypertension, lipidology, diabetes medicine, nephrology, obesity management, and preventive cardiovascular care.

Who Should Take This Course

The Continuing Education Company 29th Annual Hypertension, Diabetes, & Dyslipidemia Conference 2025 is intended for healthcare professionals involved in managing chronic cardiometabolic disease and cardiovascular risk factors.

This course is especially valuable for:

• Family medicine physicians
• Internal medicine physicians
• Endocrinologists
• Geriatric medicine specialists
• Lipidologists
• Hypertension specialists
• Nurse practitioners
• Physician assistants
• Preventive cardiology clinicians
• Primary care providers managing cardiometabolic disease

The curriculum is particularly relevant for clinicians seeking updated expertise in hypertension, diabetes, dyslipidemia, obesity medicine, and cardiovascular prevention.

Clinical Applications & Practice Benefits

The course provides clinically practical cardiometabolic education focused on improving cardiovascular outcomes and chronic disease management strategies.

Participants gain practical insight into:

• Blood pressure optimization strategies
• Diabetes and obesity treatment planning
• Lipid-lowering therapy selection
• ASCVD risk reduction approaches
• CKD-related cardiometabolic management
• Preventive cardiology integration
• Advanced metabolic pharmacotherapy
• Individualized chronic disease treatment plans
• Guideline-informed patient management
• Long-term cardiovascular prevention strategies

The educational content strengthens clinical confidence while supporting improved patient outcomes in hypertension, diabetes, dyslipidemia, and metabolic disease management.

Professional Summary

The Continuing Education Company 29th Annual Hypertension, Diabetes, & Dyslipidemia Conference 2025 provides a comprehensive and clinically practical review of modern cardiometabolic medicine, preventive cardiology, lipidology, hypertension management, and diabetes care.

Through expert-led lectures, evidence-based guideline updates, and multidisciplinary clinical discussions, the program explores chronic disease prevention, obesity medicine, cardiovascular risk reduction, renal protection, and evolving therapeutic strategies for patients with complex metabolic disease.

Its combination of practical patient management education, preventive cardiovascular focus, and expert faculty instruction makes this conference a valuable educational resource for physicians, advanced practice providers, and clinicians seeking advanced expertise in cardiometabolic disease management and cardiovascular prevention.

 Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below.